[Therapy of Waldenstrom's disease and of heavy chain disease].
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006362:Heavy Chain Disease / Q000188:drug therapy*; D006801:Humans; D007137:Immunoglobulin alpha-Chains; D007142:Immunoglobulin gamma-Chains; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014520:Urethane / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007137:Immunoglobulin alpha-Chains; D007142:Immunoglobulin gamma-Chains; D002699:Chlorambucil; D011344:Procarbazine; D014520:Urethane; D003520:Cyclophosphamide; D011239:Prednisolone
Die Therapie des Morbus Waldenström und des Heavy Chain Disease